Stargazin-EBFP2-FRB
(Plasmid
#222417)
-
PurposeTo express a plasma membrane "anchor" for rapamycin-induced heterodimerisation in mammalian cells
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 222417 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneFRB-N1
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameCacng2
-
SpeciesM. musculus (mouse)
-
Entrez GeneCacng2 (a.k.a. B230105C07Rik, B930041E13Rik, stargazer, stargazin, stg, wag, waggler)
-
Tag
/ Fusion Protein
- EBFP2-HA-FRB (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (unknown if destroyed)
- 3′ cloning site KpnI (unknown if destroyed)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2024.05.31.596797 for bioRxiv preprint.
There are two discrepancies in the Addgene sequence file compared to the canonical sequence: F325L mutation in stargazin region of stargazin-EBFP2-HA-FRB ORF, as well as a F416L mutation in EBFP2 region of stargazin-EBFP2-HA-FRB ORF. The authors confirm these mutations do not have an effect on the function of the plasmid.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Stargazin-EBFP2-FRB was a gift from Stephen Royle (Addgene plasmid # 222417 ; http://n2t.net/addgene:222417 ; RRID:Addgene_222417) -
For your References section:
Non-disruptive inducible labeling of ER-membrane contact sites using the Lamin B Receptor. Downie L, Ferrandiz N, Megan Jones M, Royle SJ. bioRxiv 2024.05.31.596797 10.1101/2024.05.31.596797